![Donald Wuchterl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 970 664 $ in data 31/05/2026
Donald A. Wuchterl currently works at Abeona Therapeutics, Inc., as Independent Director from 2021.
Mr. Wuchterl also formerly worked at Astellas Gene Therapies, Inc., as Senior VP-Technical Operations & Quality from 2016 to 2021, Cytovance Biologics, Inc., as Chief Operating Officer & Senior Vice President from 2012 to 2016, and T-Knife Therapeutics, Inc., as Senior VP & Chief Manufacturing Officer from 2021 to 2022.
Mr. Wuchterl received his undergraduate degree from Colorado Technical University, Inc. and Masters Business Admin degree from Fitchburg State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2026 | 167.935 ( 0,29% ) | 970 664 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Direttore/Membro del Consiglio | 19/04/2021 |
| Società | Posizione | Fine |
|---|---|---|
T-Knife Therapeutics, Inc.
 T-Knife Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that dedicated to developing novel therapeutics to fight cancer and provides T cell therapy services | Corporate Officer/Principal | 01/08/2022 |
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Direttore operativo | 01/01/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Health Technology |
Colorado Technical University, Inc.
 Colorado Technical University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fitchburg State University
 Fitchburg State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
T-Knife Therapeutics, Inc.
T-Knife Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that dedicated to developing novel therapeutics to fight cancer and provides T cell therapy services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
